|
US5545553A
(en)
*
|
1994-09-26 |
1996-08-13 |
The Rockefeller University |
Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
|
|
US6635462B1
(en)
*
|
1997-05-12 |
2003-10-21 |
Phoenix Pharmacologies, Inc. |
Mutated form of arginine deiminase
|
|
US6183738B1
(en)
|
1997-05-12 |
2001-02-06 |
Phoenix Pharamacologics, Inc. |
Modified arginine deiminase
|
|
US5985263A
(en)
*
|
1997-12-19 |
1999-11-16 |
Enzon, Inc. |
Substantially pure histidine-linked protein polymer conjugates
|
|
CN1328152A
(zh)
*
|
2000-06-14 |
2001-12-26 |
上海博德基因开发有限公司 |
一种新的多肽——人nrd转化酶10.01和编码这种多肽的多核苷酸
|
|
US20040096437A1
(en)
*
|
2000-07-27 |
2004-05-20 |
Bon-Hong Min |
Pharmaceutical composition comprising arginine deiminasa for inhibiting angio-genesis
|
|
WO2002009741A1
(en)
*
|
2000-07-27 |
2002-02-07 |
Angiolab, Inc. |
The pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis
|
|
AU2001289132A1
(en)
*
|
2000-11-28 |
2002-06-11 |
Phoenix Pharmacologics, Inc. |
Modified arginine deiminase
|
|
US20050063942A1
(en)
*
|
2001-02-02 |
2005-03-24 |
Clark Mike A. |
Methods for predicting sensitivity of tumors to arginine deprivation
|
|
US7173003B2
(en)
*
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
|
US7265084B2
(en)
*
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
US7399613B2
(en)
*
|
2001-10-10 |
2008-07-15 |
Neose Technologies, Inc. |
Sialic acid nucleotide sugars
|
|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
|
US7795210B2
(en)
*
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
|
EP2292273A3
(en)
*
|
2001-10-10 |
2011-11-23 |
BioGeneriX AG |
Remodeling and glycoconjugation of peptides
|
|
US7696163B2
(en)
*
|
2001-10-10 |
2010-04-13 |
Novo Nordisk A/S |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US8008252B2
(en)
*
|
2001-10-10 |
2011-08-30 |
Novo Nordisk A/S |
Factor VII: remodeling and glycoconjugation of Factor VII
|
|
US7214660B2
(en)
*
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US7179617B2
(en)
*
|
2001-10-10 |
2007-02-20 |
Neose Technologies, Inc. |
Factor IX: remolding and glycoconjugation of Factor IX
|
|
US7473680B2
(en)
|
2001-11-28 |
2009-01-06 |
Neose Technologies, Inc. |
Remodeling and glycoconjugation of peptides
|
|
DE60336555D1
(de)
*
|
2002-06-21 |
2011-05-12 |
Novo Nordisk Healthcare Ag |
Pegylierte glykoformen von faktor vii
|
|
CN100405906C
(zh)
*
|
2002-10-09 |
2008-07-30 |
尼奥斯技术有限公司 |
促红细胞生成素:促红细胞生成素的重构和糖缀合
|
|
ES2477118T3
(es)
*
|
2002-11-18 |
2014-07-15 |
Polaris Group |
Método para inhibir la replicaci�n viral in vivo
|
|
KR101031206B1
(ko)
*
|
2002-12-31 |
2011-04-27 |
넥타르 테라퓨틱스 |
말레암산 중합체 유도체 및 이의 바이오컨쥬게이트
|
|
ATE444984T1
(de)
*
|
2002-12-31 |
2009-10-15 |
Nektar Therapeutics Al Corp |
Hydrolysestabile maleimidendgruppen-enthaltende polymere
|
|
US7432331B2
(en)
*
|
2002-12-31 |
2008-10-07 |
Nektar Therapeutics Al, Corporation |
Hydrolytically stable maleimide-terminated polymers
|
|
AU2004221824B2
(en)
*
|
2003-03-14 |
2009-08-27 |
Ratiopharm Gmbh |
Branched water-soluble polymers and their conjugates
|
|
CN100522988C
(zh)
*
|
2003-04-09 |
2009-08-05 |
诺和诺德公司 |
糖peg化方法及由该方法生产的蛋白质/肽
|
|
WO2004091499A2
(en)
*
|
2003-04-09 |
2004-10-28 |
Neose Technologies, Inc. |
Intracellular formation of peptide conjugates
|
|
CA2522345A1
(en)
*
|
2003-04-09 |
2004-11-18 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
|
US7932364B2
(en)
|
2003-05-09 |
2011-04-26 |
Novo Nordisk A/S |
Compositions and methods for the preparation of human growth hormone glycosylation mutants
|
|
WO2005012484A2
(en)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Antibody-toxin conjugates
|
|
NZ547168A
(en)
*
|
2003-11-24 |
2010-05-28 |
Biogenerix Ag |
Glycopegylated erythropoietin
|
|
US20080305992A1
(en)
*
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
|
US8633157B2
(en)
*
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
|
US7790835B2
(en)
*
|
2003-12-03 |
2010-09-07 |
Nektar Therapeutics |
Method of preparing maleimide functionalized polymers
|
|
RU2400490C2
(ru)
*
|
2003-12-03 |
2010-09-27 |
Биодженерикс Аг |
Гликопэгилированный гранулоцитарный колониестимулирующий фактор
|
|
US20080318850A1
(en)
*
|
2003-12-03 |
2008-12-25 |
Neose Technologies, Inc. |
Glycopegylated Factor Ix
|
|
US7956032B2
(en)
*
|
2003-12-03 |
2011-06-07 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
|
US20060040856A1
(en)
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
|
ES2422187T3
(es)
*
|
2003-12-03 |
2013-09-09 |
Biogenerix Ag |
Factor estimulante de colonias de granulocitos glicopegilados
|
|
NZ548123A
(en)
*
|
2004-01-08 |
2010-05-28 |
Novo Nordisk As |
O-linked glycosylation of peptides
|
|
US9085659B2
(en)
|
2004-05-03 |
2015-07-21 |
Nektar Therapeutics |
Polymer derivatives comprising an imide branching point
|
|
CA2565414A1
(en)
*
|
2004-05-04 |
2005-11-24 |
Novo Nordisk Health Care Ag |
O-linked glycoforms of polypeptides and method to manufacture them
|
|
WO2006010143A2
(en)
|
2004-07-13 |
2006-01-26 |
Neose Technologies, Inc. |
Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
|
|
CN1745847A
(zh)
*
|
2004-09-08 |
2006-03-15 |
康达医药科技有限公司 |
用精氨酸酶治疗肝炎的药物组合物和方法
|
|
WO2006031811A2
(en)
*
|
2004-09-10 |
2006-03-23 |
Neose Technologies, Inc. |
Glycopegylated interferon alpha
|
|
EP1797192A1
(en)
*
|
2004-09-29 |
2007-06-20 |
Novo Nordisk Health Care AG |
Modified proteins
|
|
EP1814573B1
(en)
|
2004-10-29 |
2016-03-09 |
ratiopharm GmbH |
Remodeling and glycopegylation of fibroblast growth factor (fgf)
|
|
EP1838332A1
(en)
*
|
2005-01-06 |
2007-10-03 |
Neose Technologies, Inc. |
Glycoconjugation using saccharyl fragments
|
|
CA2593682C
(en)
|
2005-01-10 |
2016-03-22 |
Neose Technologies, Inc. |
Glycopegylated granulocyte colony stimulating factor
|
|
US20060246544A1
(en)
*
|
2005-03-30 |
2006-11-02 |
Neose Technologies,Inc. |
Manufacturing process for the production of peptides grown in insect cell lines
|
|
US9187546B2
(en)
*
|
2005-04-08 |
2015-11-17 |
Novo Nordisk A/S |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
|
FR2884717B1
(fr)
*
|
2005-04-25 |
2009-07-03 |
Erytech Pharma Soc Par Actions |
Erythrocytes renfermant de l'arginine deiminase
|
|
WO2006127910A2
(en)
*
|
2005-05-25 |
2006-11-30 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin formulations
|
|
US20080255026A1
(en)
|
2005-05-25 |
2008-10-16 |
Glycopegylated Factor 1X |
Glycopegylated Factor Ix
|
|
CA2614987C
(en)
*
|
2005-07-19 |
2013-10-08 |
Nektar Therapeutics Al, Corporation |
Method for preparing polymer maleimides
|
|
MX2008002395A
(es)
*
|
2005-08-19 |
2008-03-18 |
Neose Technologies Inc |
Factor vii y factor viia glicopegilados.
|
|
US20070105755A1
(en)
*
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
|
US20090048440A1
(en)
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
|
CN101002945B
(zh)
*
|
2006-01-20 |
2012-09-05 |
清华大学 |
一种用于肿瘤治疗的新型复合物
|
|
WO2007126808A1
(en)
|
2006-03-31 |
2007-11-08 |
Baxter International Inc |
Pegylated factor viii
|
|
US7985839B2
(en)
*
|
2006-03-31 |
2011-07-26 |
Baxter International Inc. |
Factor VIII polymer conjugates
|
|
US7645860B2
(en)
*
|
2006-03-31 |
2010-01-12 |
Baxter Healthcare S.A. |
Factor VIII polymer conjugates
|
|
US7982010B2
(en)
*
|
2006-03-31 |
2011-07-19 |
Baxter International Inc. |
Factor VIII polymer conjugates
|
|
US7534595B2
(en)
*
|
2006-06-12 |
2009-05-19 |
Biomarin Pharmaceutical Inc. |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
|
|
US7531341B1
(en)
|
2006-06-12 |
2009-05-12 |
Biomarin Pharmaceutical Inc. |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
|
|
CN101516388B
(zh)
*
|
2006-07-21 |
2012-10-31 |
诺和诺德公司 |
通过o-联糖基化序列的肽的糖基化
|
|
US8969532B2
(en)
*
|
2006-10-03 |
2015-03-03 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
|
|
WO2008060780A2
(en)
*
|
2006-10-04 |
2008-05-22 |
Novo Nordisk A/S |
Glycerol linked pegylated sugars and glycopeptides
|
|
WO2008073620A2
(en)
*
|
2006-11-02 |
2008-06-19 |
Neose Technologies, Inc. |
Manufacturing process for the production of polypeptides expressed in insect cell-lines
|
|
DK2101821T3
(da)
|
2006-12-15 |
2014-10-06 |
Baxter Healthcare Sa |
Faktor VIIA-(poly)sialinsyre-konjugat med forlænget halveringstid in vivo
|
|
EP2144923B1
(en)
*
|
2007-04-03 |
2013-02-13 |
BioGeneriX AG |
Methods of treatment using glycopegylated g-csf
|
|
US20090053167A1
(en)
*
|
2007-05-14 |
2009-02-26 |
Neose Technologies, Inc. |
C-, S- and N-glycosylation of peptides
|
|
US20080292609A1
(en)
*
|
2007-05-21 |
2008-11-27 |
Ning Man Cheng |
Use of Arginase in Combination with 5FU and Other Compounds for Treatment of Human Malignancies
|
|
EP2162535A4
(en)
*
|
2007-06-04 |
2011-02-23 |
Novo Nordisk As |
O-linked glycosylation using N-acetylglucosamine transferases
|
|
WO2008154639A2
(en)
*
|
2007-06-12 |
2008-12-18 |
Neose Technologies, Inc. |
Improved process for the production of nucleotide sugars
|
|
FR2919804B1
(fr)
|
2007-08-08 |
2010-08-27 |
Erytech Pharma |
Composition et vaccin therapeutique anti-tumoral
|
|
US7537923B2
(en)
*
|
2007-08-17 |
2009-05-26 |
Biomarin Pharmaceutical Inc. |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
|
|
US8207112B2
(en)
*
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|
|
CN102037004A
(zh)
*
|
2008-01-08 |
2011-04-27 |
生物种属学股份公司 |
使用寡糖基转移酶的多肽的糖缀合
|
|
US20130189239A1
(en)
|
2008-02-27 |
2013-07-25 |
Novo Nordisk A/S |
Conjugated Factor VIII Molecules
|
|
WO2010014225A2
(en)
|
2008-07-30 |
2010-02-04 |
Biomarin Pharmaceutical Inc. |
Assays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase
|
|
US8815232B2
(en)
|
2008-08-26 |
2014-08-26 |
Kyon Biotech Ag |
Compositions and methods for treating cancer
|
|
US20100150949A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Oncopharmacologics, Inc. |
Methods and compositions for modulating proline levels
|
|
RU2744370C2
(ru)
|
2009-07-27 |
2021-03-05 |
Баксалта Инкорпорейтед |
Конъюгаты белков свертывания крови
|
|
US8809501B2
(en)
|
2009-07-27 |
2014-08-19 |
Baxter International Inc. |
Nucleophilic catalysts for oxime linkage
|
|
BR112012001814A8
(pt)
*
|
2009-07-27 |
2018-02-06 |
Baxalta GmbH |
Conjugados de proteína de coagulação sanguínea
|
|
US8642737B2
(en)
|
2010-07-26 |
2014-02-04 |
Baxter International Inc. |
Nucleophilic catalysts for oxime linkage
|
|
EP3081233B1
(en)
|
2009-07-27 |
2020-12-23 |
Baxalta GmbH |
Glycopolysialylation of proteins other than blood coagulation proteins
|
|
EP2295560A1
(en)
|
2009-09-14 |
2011-03-16 |
RWTH Aachen University |
Directed evolution of arginine deiminase for increased activity at physiological pH
|
|
EP4062928A3
(en)
|
2010-02-04 |
2022-11-30 |
BioMarin Pharmaceutical Inc. |
Prokaryotic phenylalanine ammonia-lyases and their use for treating phenylketonuria and hyperphenylalaninemia
|
|
CN101812438B
(zh)
*
|
2010-03-25 |
2014-08-27 |
江苏泰康生物医药有限公司 |
一种精氨酸脱亚氨酶突变体及其制备与应用
|
|
WO2012075173A2
(en)
|
2010-12-01 |
2012-06-07 |
Board Of Regents The University Of Texas System |
Compositions and method for deimmunization of proteins
|
|
ES2800983T3
(es)
|
2010-12-22 |
2021-01-07 |
Baxalta GmbH |
Materiales y métodos para conjugar un derivado de ácido graso soluble en agua con una proteína
|
|
JP2014521602A
(ja)
*
|
2012-04-04 |
2014-08-28 |
ポラリス グループ |
アルギニンデイミナーゼを用いる処置方法
|
|
WO2014001956A2
(en)
*
|
2012-06-25 |
2014-01-03 |
Ning Man Cheng |
Combinational use of pegylated recombinant human arginase with chemotherapeutic/target therapeutic drug in cancer treatment
|
|
US9255262B2
(en)
|
2013-03-06 |
2016-02-09 |
Vision Global Holdings Ltd. |
Albumin-binding arginine deminase and the use thereof
|
|
USRE48805E1
(en)
|
2013-03-06 |
2021-11-02 |
Vision Global Holdings Ltd. |
Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein
|
|
WO2014151982A2
(en)
|
2013-03-15 |
2014-09-25 |
Polaris Group |
Arginine deiminase with reduced cross-reactivity toward adi – peg 20 antibodies for cancer treatment
|
|
EP3052116B1
(en)
|
2013-10-04 |
2021-05-05 |
Ann, David K. |
Arginase i, arginase ii, or adi in combiantion with doxorubicin for use in a treatmnt of a breast cancer
|
|
TWI676683B
(zh)
*
|
2014-03-14 |
2019-11-11 |
開曼群島商瑞華藥業集團 |
用於癌症治療之對adi-peg20抗體交叉反應性降低之精胺酸去亞胺酶
|
|
WO2015143006A1
(en)
*
|
2014-03-18 |
2015-09-24 |
Tdw Group |
Engineered chimeric pegylated adi and methods of use
|
|
CN103923898A
(zh)
*
|
2014-04-17 |
2014-07-16 |
江南大学 |
一种peg修饰的重组精氨酸脱亚胺酶及其制备方法和应用
|
|
TWI790481B
(zh)
|
2014-07-08 |
2023-01-21 |
開曼群島商瑞華藥業集團 |
精胺琥珀酸合成酶之抗體及相關方法
|
|
CA2961602A1
(en)
|
2014-09-16 |
2016-03-24 |
Polaris Group |
Arginine deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatment
|
|
CN104726478A
(zh)
*
|
2015-03-09 |
2015-06-24 |
武汉远大弘元股份有限公司 |
表达精氨酸脱亚胺酶基因的重组大肠杆菌及其应用
|
|
US11613759B2
(en)
|
2015-09-04 |
2023-03-28 |
Sqz Biotechnologies Company |
Intracellular delivery of biomolecules to cells comprising a cell wall
|
|
CN109415741A
(zh)
|
2016-05-03 |
2019-03-01 |
Sqz生物技术公司 |
细胞内递送生物分子以诱导耐受性
|
|
US12281339B2
(en)
|
2016-07-05 |
2025-04-22 |
Polaris Group |
Combination cancer immunotherapies with arginine depletion agents
|
|
EP3534963B1
(en)
|
2016-11-02 |
2024-04-17 |
Polaris Group |
Formulations of pegylated arginine deiminase
|
|
CN106591271B
(zh)
*
|
2017-03-02 |
2019-07-16 |
江南大学 |
一株酶活和温度稳定性提高的精氨酸脱亚胺酶突变体及其应用
|
|
WO2019042628A1
(en)
|
2017-08-31 |
2019-03-07 |
Erytech Pharma |
ARGININE DEIMINASE ENCAPSULATED WITHIN ERYTHROCYTES AND THEIR USE IN THE TREATMENT OF CANCER AND ARGINASE-1 DEFICIENCY
|
|
EP3449935A1
(en)
|
2017-08-31 |
2019-03-06 |
Erytech Pharma |
Arginine deiminase encapsulated inside erythrocytes and their use in treating cancer and arginase-1 deficiency
|
|
CN112513099A
(zh)
*
|
2018-05-31 |
2021-03-16 |
香港理工大学 |
用于癌症、肥胖症、代谢紊乱和相关并发症及合并症的精氨酸耗竭剂的组合物和应用
|
|
CN118497178A
(zh)
*
|
2023-02-15 |
2024-08-16 |
重庆派金生物科技有限公司 |
精氨酸脱亚胺酶突变体、共价二聚体及其偶联物和应用
|